Jyothi Parvathareddy
University of Tennessee Health Science Center(US)
Publications by Year
Research Areas
SARS-CoV-2 and COVID-19 Research, Computational Drug Discovery Methods, COVID-19 Clinical Research Studies, Bacillus and Francisella bacterial research, Click Chemistry and Applications
Most-Cited Works
- → Covalent narlaprevir- and boceprevir-derived hybrid inhibitors of SARS-CoV-2 main protease(2022)122 cited
- → Visualization of Murine Intranasal Dosing Efficiency Using Luminescent Francisella tularensis: Effect of Instillation Volume and Form of Anesthesia(2012)95 cited
- → Potent and selective covalent inhibition of the papain-like protease from SARS-CoV-2(2023)89 cited
- → Rapid Sequencing of Multiple RNA Viruses in Their Native Form(2019)62 cited
- → Virtual and In Vitro Antiviral Screening Revive Therapeutic Drugs for COVID-19(2020)59 cited
- → NaxD is a deacetylase required for lipid A modification and Francisella pathogenesis(2012)43 cited
- → Drug Repurposing to Identify Nilotinib as a Potential SARS-CoV-2 Main Protease Inhibitor: Insights from a Computational and In Vitro Study(2021)37 cited
- → Exposure to environmentally persistent free radicals during gestation lowers energy expenditure and impairs skeletal muscle mitochondrial function in adult mice(2016)32 cited
- → A galU mutant of francisella tularensisis attenuated for virulence in a murine pulmonary model of tularemia(2011)28 cited
- → AI-Accelerated Design of Targeted Covalent Inhibitors for SARS-CoV-2(2023)24 cited